[1] Fujita M, Komeda M, Hasegawa K, et al.Pericardial fluid as a new material for clinical heart research[J]. Int J Cardiol, 2001, 77(2-3): 113-118.
[2] Jones EA, English A, Henshaw K, et al.Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis[J]. Arthritis Rheum, 2004, 50(3): 817-827.
[3] Zhang Y, McNeill E, Tian H, et al.Urine derived cells are a potential source for urological tissue reconstruction[J]. J Urol, 2008, 180(5): 2226-2233.
[4] Ben-Horin S, Shinfeld A, Kachel E, et al.The composition of normal pericardial fluid and its implications for diagnosing pericardial effusions[J]. Am J Med, 2005, 118(6): 636-642.
[5] Beltrami C, Besnier M, Shantikumar S, et al.Human pericardial fluid contains exosomes enriched with cardiovascular-expressed microRNAs and promotes therapeutic angiogenesis[J]. Mol Ther, 2017, 25(3): 679-693.
[6] Limana F, Zacheo A, Mocini D, et al. Identification of myocardial and vascular precursor cells in human and mouse epicardium[J]. Circ Res, 2007, 101(12): 1255-1265.
[7] Foglio E, Puddighinu G, Fasanaro P, et al. Exosomal clusterin, identified in the pericardial fluid, improves myocardial performance following MI through epicardial activation, enhanced arteriogenesis and reduced apoptosis[J]. Int J Cardiol, 2015, 197: 333-347.
[8] Ji X, Wang M, Chen F, et al. Urine-derived stem cells: the present and the future[J],Stem Cells Int,2017, 2017:4378947.
[9] Patouraux S,Rousseau D,Bonnafous S, et al. CD44 is a key player in non-alcoholic steatohepatitis[J], J Hepatol, 2017,67(2):328-338.
|